D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
SMNRW holding history
Semnur Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SMNRW overviewAll 13F holders of SMNRWFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −225,000−100.0% | Sold out | Holders |
| Q1 2025 | 225,000 | $13.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 225,000 | $8.37K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 225,000 | $11.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 225,000 | $4.72K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 225,000 | $11.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 225,000 | $11.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 225,000 | $13.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 225,000 | $11.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 225,000 | $13.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 225,000 | $9.56K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 225,000 | $18.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 225,000 | $23.0K | <0.1% | +225,000 | New | Holders |